Enzon Pharmaceuticals Inc
(ENZN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Sales | 51,408 | 56,969 | 185,601 | 185,653 | 0 |
| Cost of Goods | N/A | N/A | 54,978 | 50,121 | N/A |
| Gross Profit | 51,408 | 56,969 | 130,623 | 135,532 | N/A |
| Operating Expenses | 108,501 | 98,458 | 41,107 | 125,153 | 0 |
| Operating Income | -57,093 | -41,489 | 90,494 | 10,500 | N/A |
| Interest Expense | 11,514 | 12,681 | 17,380 | 22,055 | 0 |
| Other Income | 9,320 | 7,858 | 11,872 | 33,622 | 0 |
| Pre-tax Income | -59,287 | -46,312 | 84,986 | 22,067 | 0 |
| Income Tax | -2,085 | 255 | 1,933 | 758 | N/A |
| Net Income Continuous | -57,202 | -46,567 | 83,053 | 21,309 | N/A |
| Net Income Discontinuous | 57,885 | 43,852 | N/A | N/A | N/A |
| Net Income | $683 | $-2,715 | $83,053 | $21,309 | $N/A |
| EPS Basic Total Ops | 0.02 | -0.06 | 1.89 | 0.49 | N/A |
| EPS Basic Continuous Ops | -1.26 | -1.05 | 1.89 | 0.49 | N/A |
| EPS Basic Discontinuous Ops | 1.28 | 0.99 | N/A | N/A | N/A |
| EPS Diluted Total Ops | 0.02 | -0.06 | 1.29 | 0.46 | N/A |
| EPS Diluted Continuous Ops | -1.26 | -1.05 | 1.14 | 0.35 | N/A |
| EPS Diluted Discontinuous Ops | 1.28 | 0.99 | N/A | N/A | N/A |
| EBITDA(a) | $-49,900 | $-37,192 | $109,172 | $28,783 | $N/A |